Hopes and concerns over a new Alzheimer's drug
The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the drug's approval process has stirred controversy.